There (IVSA) Fair Value & Analysis
Other · DE · Market cap €66.8B
Fair value as of: Jul 25, 2026
From 22 valuation models · updated 16 days ago
Fair value updated Jul 25, 2026, revised from €68.02 to €67.80 (−0.3%) since Jun 25, 2026. Share price +3.9% over the past month.
A solid business, screening 96% undervalued on our models.
What matters now
- The price is below even our cautious bear case (€48.95). The market is more pessimistic than our downside scenario.
- The model range is unusually wide (€48.95 to €155.33). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.
How to read this chart
60‑month range €15.65 – €35.55 · fair‑value band €48.95 – €155.33 · the €34.59 price screens below the €67.80 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 25, 2026.
Analysis
There (IVSA) currently trades at €34.59, while our model-based Fair Value estimate is €67.80, implying the stock looks roughly 96.0% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Other sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Net debt stands at €97.9B. Fundamentals as of Jul 25, 2026
Our scenario range runs from €48.95 (bear case) to €155.33 (bull case); at €34.59, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 44% above its 52-week low, currently above its 200-day average. For context, the median of 10 Other peers we cover trades at -22% fair-value upside, at 96%, IVSA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 22 models by family
Widest divergence: Growth Earnings (€3,513) versus Dividend Discount (€132.83). Highest evidence: Growth DCF (80).
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 74
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
There is no Profile data available for IVSA.BE.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
There reported revenue of €217B in FY2025 versus €265B in FY2021, a compound −4.9%/yr. Reported net income was €157B in FY2025, compounding −8.8%/yr from FY2021.
Watch IVSA: get an alert when its fair value changes →
Peer Group
Other · 390 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Other median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Federal Home Loan Mortgage Corporation FREJO | $15.84 | $52.77 | +233% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹191.93 | -87% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
| 540777 540777 | ₹567.55 | ₹142.69 | -75% |
| Lupin Limited 500257 | ₹2,476 | ₹1,983 | -20% |
| 540719 540719 | ₹1,788 | ₹850.02 | -52% |
| 524804 524804 | ₹1,620 | ₹1,268 | -22% |
| 540716 540716 | ₹1,612 | ₹1,224 | -24% |
| Eicher Motors Limited 505200 | ₹7,340 | ₹6,859 | -7% |
Compare There with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is There (IVSA) overvalued or undervalued?
What is the fair value of IVSA?
What is the quality score of IVSA?
What is the net profit margin of IVSA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track There and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.